Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota |
PMID[17581819] |
|||
NPO1797 | Homo sapiens | Species | Hominidae | Eukaryota | urine |
PMID[19309105] |
||
NPO20338 | Mus musculus | Species | Muridae | Eukaryota |
PMID[19425150] |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT32 | Organism | Mus musculus | Mus musculus | LD50 | = | 450 | mg/kg | 6887207 |
NPT32 | Organism | Mus musculus | Mus musculus | Survival | = | 95 | % | 6887207 |
NPT32 | Organism | Mus musculus | Mus musculus | Survival | = | 80 | % | 6887207 |
NPT32 | Organism | Mus musculus | Mus musculus | Survival | = | 45 | % | 6887207 |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 200000 | nM | 9357523 |
NPT315 | Cell Line | CEM-SS | Homo sapiens | EC50 | = | 41600 | nM | 9207937 |
NPT315 | Cell Line | CEM-SS | Homo sapiens | IC50 | = | 71000 | nM | 9207937 |
NPT315 | Cell Line | CEM-SS | Homo sapiens | EC50 | = | 53700 | nM | 9207937 |
NPT315 | Cell Line | CEM-SS | Homo sapiens | IC50 | > | 100000 | nM | 9207937 |
NPT1 | Others | Radical scavenging activity | Inhibition | = | 37 | % | 16309906 | |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 80 | % | 17126019 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | 40 | % | 17126019 |
NPT29 | Organism | Rattus norvegicus | Rattus norvegicus | Activity | = | -7 | ug | 17126019 |
NPT613 | Individual Protein | Solute carrier family 22 member 1 | Homo sapiens | Inhibition | = | 2.4 | % | 18788725 |
NPT312 | Organism | Saccharomyces cerevisiae | Saccharomyces cerevisiae | Potency | = | 8199.5 | nM | PubChem BioAssay data set |
NPT210 | Individual Protein | Thyroid stimulating hormone receptor | Homo sapiens | Potency | = | 39810.7 | nM | PubChem BioAssay data set |
NPT109 | Individual Protein | Cytochrome P450 3A4 | Homo sapiens | Potency | = | 1000 | nM | PubChem BioAssay data set |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 5323.3 | nM | PubChem BioAssay data set | |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 14125.4 | nM | PubChem BioAssay data set | |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 18887.6 | nM | PubChem BioAssay data set | |
NPT198 | Individual Protein | Vitamin D receptor | Homo sapiens | Potency | 19952.6 | nM | PubChem BioAssay data set | |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 5972.8 | nM | PubChem BioAssay data set | |
NPT698 | Individual Protein | Regulator of G-protein signaling 4 | Homo sapiens | Potency | 7519.3 | nM | PubChem BioAssay data set | |
NPT7 | Individual Protein | Thioredoxin reductase 1, cytoplasmic | Rattus norvegicus | Potency | 19952.6 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 29855.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 29849.3 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC326253 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC326253 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD7382 | Approved |
1.0 | High Similarity | NPD7381 | Approved |
0.6552 | Remote Similarity | NPD7380 | Approved |
0.6129 | Remote Similarity | NPD8233 | Phase 3 |
0.6129 | Remote Similarity | NPD7372 | Phase 2 |
0.6087 | Remote Similarity | NPD7383 | Phase 3 |
0.56 | Remote Similarity | NPD8560 | Clinical (unspecified phase) |
Molecular Weight:   | 77.03 |
ALogP:   | -0.2157 |
MLogP:   | 1.46 |
XLogP:   | 0.106 |
# Rotatable Bonds:   | 3 |
Polar Surface Area:   | 64.82 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 1 |
# Rings:   | 0 |
# Heavy Atoms:   | 4 |